Private company

Athenex, Inc.

Last updated Oct 16, 2026.

Overview

  • IndustryPharmaceutical Preparations
  • HeadquartersDE
  • Incorporated inDE2
  • Business address1001 Main Street, Suite 600, Buffalo, Ny 142032
  • Filer categoryNon-accelerated filer, Smaller reporting company2

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2022

26.0%Gross margin3
-68.1%Operating margin3
-100.6%Net margin3
7.8%Revenue growth, 20223

Where the money goes

Where each dollar of revenue went, fiscal 2022

  • Cost of revenue38¢$76.1M
  • Research and development26¢$51.8M
  • Selling, general and admin23¢$44.9M
  • Interest13¢$25.8M
  • Income tax0¢$347.0K

Out of $102.8M in revenue.3 The company lost money this year.

Financial statements

Revenue45673$102.8M in 2022+400% since 2016
0$50.0M$100.0M$150.0M2016: $20.6M$20.6M20162017: $38.0M$38.0M2017+85%2018: $89.1M$89.1M2018+134%2019: $101.2M$101.2M2019+14%2020: $144.4M$144.4M2020+43%2021: $95.4M$95.4M2021−34%2022: $102.8M$102.8M2022+8%
Gross profit673$26.7M in 2022−37% since 2018
0$20.0M$40.0M$60.0M2018: $42.1M$42.1M20182019: $31.6M$31.6M2019−25%2020: $49.0M$49.0M2020+55%2021: $32.5M$32.5M2021−34%2022: $26.7M$26.7M2022−18%
Operating income45673-$70.0M in 2022−18% since 2016
-$200.0M-$150.0M-$100.0M-$50.0M02016: -$85.7M-$85.7M20162017: -$110.0M-$110.0M2017+28%2018: -$126.8M-$126.8M2018+15%2019: -$119.0M-$119.0M2019−6%2020: -$119.7M-$119.7M2020+1%2021: -$150.4M-$150.4M2021+26%2022: -$70.0M-$70.0M2022−53%
Net income45673-$103.4M in 2022+18% since 2016
-$200.0M-$150.0M-$100.0M-$50.0M02016: -$87.7M-$87.7M20162017: -$131.2M-$131.2M2017+50%2018: -$117.4M-$117.4M2018−10%2019: -$123.7M-$123.7M2019+5%2020: -$146.2M-$146.2M2020+18%2021: -$199.8M-$199.8M2021+37%2022: -$103.4M-$103.4M2022−48%
Fiscal year2016201720182019202020212022
Revenue$20.6M4$38.0M5$89.1M6$101.2M7$144.4M7$95.4M3$102.8M3
Cost of revenue$19.7M4$25.1M5$47.0M6$69.6M7$95.4M7$62.9M3$76.1M3
Gross profit$42.1M6$31.6M7$49.0M7$32.5M3$26.7M3
Research and development$60.6M4$76.8M5$119.9M6$84.4M7$75.9M7$77.7M3$51.8M3
Selling, general and admin$26.0M4$46.1M5$49.0M6$66.3M7$92.9M7$64.2M3$44.9M3
Operating income-$85.7M4-$110.0M5-$126.8M6-$119.0M7-$119.7M7-$150.4M3-$70.0M3
Interest$1.9M8$6.3M5$3.6M6$7.0M7$11.2M7$20.7M3$25.8M3
Income tax-$265.0K4$85.0K5$100.0K6$928.0K7$4.1M7-$10.6M3$347.0K3
Net income-$87.7M4-$131.2M5-$117.4M6-$123.7M7-$146.2M7-$199.8M3-$103.4M3
Earnings per share-$38.443-$15.813
Earnings per share (diluted)-$38.443-$15.813

Compare Athenex, Inc. with another company

Former names

  • Kinex Pharmaceuticals, Inc.Dec 23, 2013 to Jun 16, 20152
  • Kinex Pharmaceuticals LLCAug 13, 2004 to Aug 6, 20122

Recent filings

  1. Oct 2, 20238-K
  2. Aug 17, 20238-K
  3. Jul 18, 20238-K
  4. May 22, 20238-K
  5. May 8, 20234 FORM 4 SUBMISSION
  6. May 8, 20234 FORM 4 SUBMISSION
  7. May 8, 20234 FORM 4 SUBMISSION
  8. May 3, 20238-K
  9. Apr 28, 202310-K/A
  10. Apr 25, 20238-K
  11. Apr 24, 20234 FORM 4 SUBMISSION
  12. Apr 24, 20234 FORM 4 SUBMISSION
  13. Apr 24, 20234 FORM 4 SUBMISSION
  14. Apr 24, 20234 FORM 4 SUBMISSION
  15. Apr 24, 20234 FORM 4 SUBMISSION

Every filing from the last three years, summarized. The full record is on SEC EDGAR.1

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8